Can be processed on standard injection molding machines Avient Long Fiber Technology Product/Service Overview

Avient Protective Materials Avient Canada ULC Avient Quality Policy

Avient’s Singapore Production Facility Receives ISCC PLUS Certification for Bio-Derived Materials Avient’s Singapore Production Facility Receives ISCC PLUS Certification for Bio-Derived Materials... Mar 10, 2025

Medical Overmolding Avient has several USP VI overmolding products available for use in medical device applications. Overmolding to a wide variety of modified and filled nylons is now possible with solutions from Avient. OnFlex™ S KG – Enhanced processing for bi-injection molding

Browse and download our literature to learn more about Avient solutions and services. Important information about the health, safety and environmental impacts of Avient products. Comprehensive guide for designing molded parts with Nymax nylon formulations

Important information about the health, safety and environmental impacts of Avient products. Product Selection Guide Learn how Avient's pre-dispersed colorants and additives give you the consistency and quality your products deserve

Actions included the election of the following 10 individuals to serve on the company's Board of Directors until the 2020 annual meeting:

Validation Avient Colorants Sweden AB and Avient Colorants Lewiston, ME follow the Global Harmonization Task Force guideline GHTF/SG3/N99-10 to define the procedure for process validation. Control of Non-conforming products, complaints handling, recall and CAPA Avient follows a documented process for control of non- conforming products, complaints handling, recall and CAPA. At Avient, we create specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.

Connect with a Product Expert Important information about the health, safety and environmental impacts of Avient products. Injection molding parameters, startup and shutdown, mold design and troubleshooting recommendations for Stat-Tech™ Static Dissipative and Conductive Formulations

Page 93 • Versus 2010, revenue growth of 9% drives 23% increase in adjusted operating income • Adjusted EPS expands 29% to all-time high of $1.02 Net Sales Adjusted Operating $1.02 Adjusted EPS $2,622 $2,643 $2,739 $2,061 $2,622 $2,864 Net Sales $88 $87 $72 $59 $147 $181 Adjusted Operating Income $0.12 $0.27 $0.21 $0.13 $0.79 $1.02 ($ millions) ($ millions) Page 94 • Each platform contributed to our year over year operating income growth • Record OI achieved in Specialty and POD • Ten quarters of double-digit adjusted EPS expansion POD PP&SSpecialty Platform ROS%* 0.6% 1.5% 3.2% 4.3% 5.3% 8.4% 8.0% 2.9% 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% 6.7% 5.5% 6.1% 3.1% 5.0% 7.0% 7.2% $20 $19 $22 $28 $25 $42 $56 I POD $76 $64 $66 $31 $33 $54 $62 In PP&S $5 $13 $31 $46 $46 $87 $89 I Specialty Platform *ROS% is defined as adjusted operating income % of revenue Page 95 • Continued portfolio repositioning � Sale of SunBelt equity investment � Acquisition of specialty companies ColorMatrix and Uniplen • World-class working capital of 9.6% maintained while improving on-time delivery to 94%improving on-time delivery to 94% 81% 87% 88% 95% 93% 92% 94% 2005 2006 2007 2008 2009 2010 2011 14.3% 16.2% 14.4% 18.9% 11.7% 9.6% 9.6% 2005 2006 2007 2008 2009 2010 2011 On-Time Delivery Working Capital % of Sales Page 96 First Quarter 2012 Highlights • Revenues increased 9% over Q1 2011 to a new quarterly record • Adjusted EPS increased 12% $0.26 $0.29 Adjusted EPS • Adjusted EPS increased 12% over prior year • All platforms delivered double-digit operating income growth $25.2 $14.7 $29.1 $17.8 $16.7 Specialty PP&S POD Adjusted Operating Income $14.3 Page 97 • Total Debt at 3/31/12 Less: Cash Net Debt • Available Liquidity $706 186 $520 $360 $250 $350 $400 $450 Debt Maturities As of March 31, 2012 Debt Maturities & Liquidity Summary – 3/31/12 • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA* = 1.9x $186 156 $342 *Adjusted EBITDA TTM Pro forma for ColorMatrix $50 $0 $50 $100 $150 $200 $250 2015 2017 2020 Page 98 • Repurchased 6 million shares in 2011 Share Share RepurchaseRepurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 DividendsDividends • Expanding our sales, marketing, and technical capabilities is top Organic Organic GrowthGrowth • Targets that expand our: • Specialty offering • End market presence AcquisitionsAcquisitions Use of Cash Current Cash Balance = $186M Net Debt / EBITDA* = 1.9X • 7.9 million shares remain available for repurchase under the current authorization increased in Q1 2012 • Objective of maintaining and growing capabilities is top priority • Investing in operational and LSS initiatives • CAPEX • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions *Adjusted EBITDA TTM Pro forma for ColorMatrix Page 99 Page 100